Radioembolization Versus Bland or Chemoembolization for Liver-Dominant Neuroendocrine Tumors: Is It an Either/Or Question?
Jonathan Strosberg, Ghassan El‐Haddad, Taymeyah Al‐Toubah, Diane Reidy‐Lagunes, Etay Ziv, Armeen Mahvash, Arvind Dasari, Philip A. Philip, Michael C. Soulen
Abstract
Hepatic arterial embolization has been used for decades to treat liver-dominant metastatic neuroendocrine tumors (NETs). During the 1970s–1990s, transarterial bland hepatic arterial embolization (TAE) and chemoembolization (TACE) techniques were developed ([ 1 ][1],[ 2 ][2]). Numerous studies have
Topics & Concepts
Neuroendocrine tumorsEmbolizationMedicineMicrosphereRadiologyArterial EmbolizationInternal medicineEngineeringChemical engineeringNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesRadiopharmaceutical Chemistry and Applications